Covered recipient · General Payments record
DHIREN PATEL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$1,777.60
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $449.11 | 16 |
| Education | $84.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $186.10 | 4 |
| HARMONY BIOSCIENCES LLC | $120.63 | 3 |
| ABBVIE INC. | $47.79 | 2 |
| EISAI INC. | $40.93 | 2 |
| Averitas Pharma Inc. | $38.84 | 1 |
| Avadel CNS Pharmaceuticals, LLC | $36.44 | 2 |
| BAXTER HEALTHCARE | $26.12 | 1 |
| Merz Pharmaceuticals, LLC | $19.85 | 1 |
| OptiNose US, Inc. | $17.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.30 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105193271 | CMS |
| ABBVIE INC. | $24.49 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105193273 | CMS |
| Avadel CNS Pharmaceuticals, LLC | $20.93 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123386044 | CMS |
| Avadel CNS Pharmaceuticals, LLC | $15.51 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123386046 | CMS |
| Averitas Pharma Inc. | $38.84 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133440518 | CMS |
| Baxter Healthcare | $26.12 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118299086 | CMS |
| Celgene Corporation | $6.69 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101196055 | CMS |
| Celgene Corporation | $12.73 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101196069 | CMS |
| Celgene Corporation | $4.30 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101196073 | CMS |
| Celgene Corporation | $162.38 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101196081 | CMS |
| Eisai Inc. | $18.59 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741837 | CMS |
| Eisai Inc. | $22.34 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741839 | CMS |
| Harmony Biosciences Llc | $19.36 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141476710 | CMS |
| HARMONY BIOSCIENCES LLC | $16.28 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126062348 | CMS |
| HARMONY BIOSCIENCES LLC | $84.99 | 10/21/2024 | Education | Undisputed | 01/23/2026 | 1126059456 | CMS |
| Merz Pharmaceuticals, LLC | $19.85 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137948622 | CMS |
| Optinose US, Inc. | $17.40 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142193626 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.